Iovance Biotherapeutics
IOVA
IOVA
93 hedge funds and large institutions have $387M invested in Iovance Biotherapeutics in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
82% less call options, than puts
Call options by funds: $1.55M | Put options by funds: $8.43M
Holders
93
Holding in Top 10
3
Calls
$1.55M
Puts
$8.43M
Top Buyers
| 1 | +$19.2M | |
| 2 | +$10.8M | |
| 3 | +$10M | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
+$5.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.31M |
Top Sellers
| 1 | -$9.94M | |
| 2 | -$4.38M | |
| 3 | -$1.73M | |
| 4 |
Millennium Management
New York
|
-$1.25M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$995K |